Introduction to the second issue of the first issue of the RSC database "Member Lecture Hall"

Release time: 2021-06-22

Source of the article: Reference Department

Author of the article: Zhang Bin

● Overview of RSC database :

The Royal Society of Chemistry ( RSC ) is an internationally authoritative academic institution and a major dissemination agency and publisher of chemical information. Its journals and databases have always been the core journals and authorities in the field of chemistry. Sexual database. Founded in 1841 , the association is a professional academic group composed of 55,000 chemical researchers, teachers, and industrialists. The journals and databases it publishes have always been the core journals and authoritative databases in the field of chemistry. RSC journals are mostly indexed by SCI and are the most cited chemical journals. The average impact factor in 2020 is 6.74 , of which more than 48% of journals are higher than 5.0 , involving chemistry and chemical engineering, materials, biology, pharmaceuticals, environmental protection, and food processing. In fields such as journals, e-books, past publications, abstract databases, and free ChemSpider chemical professional search engine, it is an important source of information for academic research.

● Meeting name : The Second Session of the Lecture Hall for Fellows |We sincerely invite to participate in the "Dialogue with Fellows"

● meeting time : 2021 Nian 6 Yue 25 Ri 14: 00-16: 30

● Moderator: Professor Jiao Ning ( Associate Editor of Chemical Science , Professor of School of Pharmacy, Peking University )

Host introduction:

Professor of the School of Pharmacy of Peking University, doctoral supervisor, deputy director of the State Key Laboratory of Natural Medicines and Biomimetic Medicines, Changjiang Scholars Distinguished Professor, winner of the National Science Fund for Distinguished Young Scholars, and a leader in technological innovation in the National Ten Thousand Talents Program Research directions include green synthetic chemistry, greening of drug synthesis, discovery of new drugs based on metabolic diseases, etc. A series of innovative results have been achieved in the research of oxidation reactions, nitridation reactions, and halogenation reactions. Through the development of mild and green new reactions, high-efficiency synthesis of active pharmaceutical intermediates, structural modification and transformation, and new drug discovery are completed. The corresponding author has published 173 papers in journals such as Science , Nat. Chem. , Nat. Catal. , he has cited more than 13,000 times, edited two monographs, and authorized more than 10 patents. He has successively won the First Prize of Natural Science of the Ministry of Education (the first completer ) , the First Prize of Beijing Natural Science (the first completer), the Chinese Chemical Society - BASF Corporation Young Knowledge Innovation Award, the Roche Chinese Young Investigator Award , and China Homogeneous Various funding and awards including the Catalytic Youth Award. Served as the deputy editor of Chem. Sci. and the editorial board of several domestic and foreign journals.

● Lecturer: Professor Ding Ke ( Dean and Professor of School of Pharmacy, Jinan University )

Lecture topic: Drug development based on protein kinases: Is it "the end of the crossbow" or "the myth of immortality"?

Speaker introduction:

Dean, professor and doctoral supervisor of the School of Pharmacy of Jinan University. Research work focuses on major clinical needs such as tumors and metabolic diseases, designing and synthesizing "pharmaceutical lead compounds" with both biological activity and druggability, laying the foundation for innovative drug research. In recent years, successfully designed and synthesized: 1 ) Bcr-AblT315I mutant inhibitor; 2 ) Highly selective EGFRT790M mutation inhibitor; 3 ) New Axl/Flt3 dual inhibitor; 4 ) The world's first subtype selective ERRa agonist ; 5 ) The world's first selective ZAK inhibitor; and 6 ) The world's first selective DDR1 inhibitor and more than 100 drug-like lead compounds . He has published more than 190 SCI papers , which have been cited by him nearly 7,000 times. Applied for more than 60 national and international invention patents , 50Many have been authorized, and many results have been transferred and transformed. Won a number of awards and honorary titles, including "Special Government Allowance by the State Council", "Changjiang Scholars Distinguished Professor" by the Ministry of Education, "Leading Talents in National Ten Thousand Talents Program" by the Organization Department of the Central Committee, "Leading Talents in Young and Middle-aged Science and Technology Innovation" by the Ministry of Science and Technology, and National Outstanding Talents Youth Fund, special government allowances of the State Council, etc. He is currently the Deputy Director of the Pharmaceutical Chemistry Professional Committee of the Chinese Pharmaceutical Association; the Deputy Editor-in-Chief of the American Chemical Society J. Med. Chem. and the International Advisory Board Member of ACS Med. Chem. Lett .; J. Chin. Pharm. Sci .

● Guest speaker: Dr. Li Jin ( CEO of Chengdu Leading Medicine Co., Ltd. )

Lecture topic: DEL (DNA ENCODED LIBRARY)-Organic Fusion of Chemistry and Biology to Empower New Drug Research

Speaker introduction:

Founder, Chairman and CEO of Chengdu Leading Drug Development Co., Ltd., Fellow of the Royal Society of Chemistry, Distinguished Professor of Sichuan University, etc. Dr. Li Jin has nearly 30 years of experience in new drug development and management. He has served as a senior executive in AstraZeneca, a Fortune 500 company for 11 years. He has more than 20 years of work experience in the fields of molecular design, molecular synthesis and molecular screening , and has published 39 papers and books in relevant international scientific journals , and has 36 authorized invention patents . Since its establishment in 2012 , Chengdu Pioneer has developed into the most advanced drug discovery field with core technologies in the design, synthesis and screening of DNA- encoded compound libraries ( DEL ), and drug design based on molecular fragments and three-dimensional structure information ( FBDD/SBDD ). One of the most influential companies. Established a wide range of international R&D cooperation and independent research and development of new drug project pipelines. 2020 Nian 4 Yue 16 , Chengdu pilot ( 688222.SH ) to become the first Southwest Branch board of listed companies.

● Journal Introduction:

Chemical Science is an interdisciplinary comprehensive journal covering various fields of chemical science and the flagship journal of the Royal Society of Chemistry. The published papers should not only be of great significance in the corresponding field, but also should arouse the wide interest of readers in other fields of chemical science. Published papers should contain major advances, conceptual innovations and advances, or insights into the development of the field. The scope of publications includes but is not limited to organic chemistry, inorganic chemistry, physical chemistry, materials science, nanoscience, catalysis, chemical biology, analytical chemistry, supramolecular chemistry, theoretical chemistry, computational chemistry, green chemistry, energy and environmental chemistry, etc. As a golden open-access journal, readers can get the full text of published papers for free. At the same time, the publication fee for the papers from the journal is borne by the Royal Society of Chemistry, and the authors of the papers do not need to pay.

● Meeting notes:

1. How to register?

Scan or recognize the following QR code in WeChat:

2. Participation method:

Please go to the registration website to register in advance. After successful registration, you will receive a confirmation email from Zoom Webinar and a link to participate.

During the listening process, you can ask your own questions through the dialog box, and we will have staff responsible for collecting and sorting out the questions to ask the speaker and get answers. .

3. The registration page sometimes opens slowly, please wait patiently or refresh it several times (also consider switching to a different network to try). If you encounter problems, you can also send your registration information to RSCChina@rsc.org .

4. This online communication and sharing meeting will be held on the zoom platform. The platform supports computers, mobile phones and other systems to facilitate the audience and the host to ask questions and interact; in order to get the best participation experience, it is recommended to install the zoom desktop software or Mobile App : https://zoom.us/download